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INTRODUCTION
In Korea, alcohol abuse is a serious health issue in terms of 
the amount consumed and behaviors related to its consump-
tion.1 According to the Korea National Health and Nutrition 
Examination Survey (KNHANES) 2013,2 the percentage of in-
dividuals that consumed alcohol at least once a month com-
prised approximately 55% in 2005 and 60% in 2013, showing 
an increasing trend. Heavy drinkers (those who consume at 
least three glasses of alcohol per day) reportedly accounted 
for one in four men, while men in their 40s and 50s exhibited 
the highest alcohol abuse and dependency rates. In addition, 
the KNHANES revealed that the high-risk drinking rates by 
sex, as well as the proportion of youths exposed to alcohol, have 
gradually increased.2
It is generally accepted that alcohol abuse has negative ef-
fects on health and quality of life; thus, guidelines for the regu-
lation of alcohol consumption at a global level have been sug-
gested. An example of this would be the “Global Strategy to 
Reduce the Harmful Use of Alcohol” proposed by the World 
Health Organization.3 In the United States, alcohol prevention 
programs and services, such as AlcoholEdu and Project ALERT, 
have been initiated to regulate alcohol-associated risks.4 In 
Korea, however, although an age limit for alcohol consumption 
is in effect, there are no specific regulations on the time and 
place of alcohol sales. Moreover, South Korea has no national 
agency or independent research institution for developing 
guidelines and policies on alcohol consumption. The absence 
of a detailed national policy on alcohol consumption in Korea 
has led to a culture of binge drinking and an increase in the 
Alcohol Consumption, Aldehyde Dehydrogenase 2 Gene 
Polymorphisms, and Cardiovascular Health in Korea
Min-Jeong Shin1, Yoonsu Cho1,2, and George Davey Smith2
1Department of Public Health Sciences, BK21PLUS Program in Embodiment: Health-Society Interaction, Graduate School, Korea University, 
Seoul, Korea; 
2MRC Integrative Epidemiology Unit, School of Social & Community Medicine, University of Bristol, Bristol, UK.
Alcohol consumption is a serious health issue in Korea in terms of the amount consumed and the behavior related to its con-
sumption. Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme in alcohol metabolism that degrades acetaldehyde to nontoxic 
acetic acid. The enzyme is coded by the ALDH2 gene, which is commonly polymorphic in East Asian populations. A point muta-
tion in the ALDH2 gene (the rs671 allele) yields an inactive form of ALDH2 that causes acetaldehyde accumulation in the body 
after alcohol consumption, thereby inhibiting normal alcohol metabolism. Individuals who are homozygous for polymorphism 
in ALDH2 tend to refrain from drinking alcohol, decreasing their chances of developing alcoholism and exposure to the associat-
ed risks. Mendelian randomization (MR) studies have demonstrated that alcohol consumption predicted by ALDH2 genotype is 
causally related to cardiovascular risks. Moreover, recent MR studies suggest that the ALDH2 variant has mechanistic effects on 
some disease outcomes or mortality through increased blood levels of acetaldehyde, showing differences therein between het-
erozygotes (ALDH2*2*2) and homozygotes (ALDH2*1*2) in those who consume alcohol. Accordingly, consideration of ALDH2 
genotype in alcohol prevention programs is warranted. In conclusion, strategies that incorporate genetic information and pro-
vide an evidential basis from which to help people make informed decisions on alcohol consumption are urgently required.
Key Words:  Alcohol, aldehyde dehydrogenase 2, Mendelian randomization analysis, guidelines
Review Article 
pISSN: 0513-5796 · eISSN: 1976-2437
Received: March 10, 2017   Revised: April 27, 2017
Accepted: May 2, 2017
Corresponding author: Dr. Min-Jeong Shin, Department of Public Health Sciences, 
Graduate School, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea.
Tel: 82-2-3290-5643, Fax: 82-2-940-2849, E-mail: mjshin@korea.ac.kr
•The authors have no financial conflicts of interest.
© Copyright: Yonsei University College of Medicine 2017
This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/4.0) which permits unrestricted non-commercial use, distribution, and repro-
duction in any medium, provided the original work is properly cited.
Yonsei Med J 2017 Jul;58(4):689-696
https://doi.org/10.3349/ymj.2017.58.4.689
690
Alcohol, ALDH2, and Cardiovascular Health
https://doi.org/10.3349/ymj.2017.58.4.689
incidence of alcohol-related accidents. Therefore, we find it 
necessary to focus on the control of alcohol abuse in this pop-
ulation.
It has been suggested that individual alcohol sensitivity and 
its influence are affected by genotype. The aldehyde dehydro-
genase (ALDH2) gene encodes the major enzyme responsible 
for alcohol metabolism, which eliminates acetaldehyde.5 The 
ALDH2 gene is polymorphic in East Asians, including Kore-
ans, and influences blood levels of acetaldehyde and behavior 
after consumption, which is associated with the risk for alco-
holic cirrhosis, cardiovascular disease (CVD), and cancer.6-10 The 
ALDH2 polymorphism is associated with a flushing response 
to alcohol use and lowers alcohol consumption, which acts as 
protective factors for CVDs.6,11 A previous study has reported 
that ALDH2*2 homozygotes and heterozygotes had 18 and 5 
times higher blood alcohol levels, respectively, than ALDH2*1 
homozygotes after drinking the same amount of alcohol.12 
Thus, it has been suggested that intervention for alcohol use 
should be individually specified, considering genotype infor-
mation. In this review, we highlight the role of ALDH2 poly-
morphisms in alcohol-related health problems in Koreans. 
We also propose an educational model incorporating genetic 
information on ALDH2 that may improve alcohol consump-
tion-related behaviors in this population.
ALCOHOL: A MAJOR PREVENTABLE RISK 
FOR HEALTH PROBLEMS
A number of epidemiologic studies have found that alcohol 
intake has both positive and negative effects on cardiovascular 
health. It has been generally reported that high alcohol intake 
is a risk factor for diabetes and CVDs.13,14 On the other hand, 
other epidemiological evidence have suggested that moderate 
alcohol consumption might have a protective effect against 
chronic diseases, reflected in the so-called J-shaped associa-
tion.15 However, the results of observational studies have limi-
tations because they are affected by confounding variables or 
reverse causation when investigating the association between 
alcohol consumption and the risk for chronic diseases.16 For 
example, people who stopped drinking, used as a control for 
moderate drinkers, may do so because of health problems, in-
dicating reverse causation. In supporting this, Ng Fat, et al.17 
confirmed that poor health directly influenced nondrinking 
throughout the life course, indicating a sick-quitter bias. Con-
sistently, a recent meta-analysis18 found that a reduction in mor-
tality risk in moderate drinkers (one to two glasses a day) was 
not supported when they were compared with intermittent 
drinkers (at most one glass a week/intake of less than 1.3 g per 
day) or those who never drank. In other words, the lower mor-
tality risk in intermittent drinkers can be explained by reverse 
causation or confounding variables, rather than by the amount 
of alcohol intake. Hence, it is difficult to conclude that lowering 
alcohol intake reduces mortality. Furthermore, it has also been 
reported that there is no association between limited alcohol 
intake and cancer- or cardiovascular-related mortality19 and 
that even moderate drinking can be harmful.20 For these rea-
sons, the International Agency for Research on Cancer classified 
alcohol as a Group 1 carcinogen,21 while the European Union 
enhanced their cancer prevention guidelines to include “no 
alcohol drinking” in 2014.22 Following these global recommen-
dations, the Ministry of Health and Welfare of South Korea re-
vised their guidelines in March 2016 to “To prevent cancer, 
drinking even small amounts of alcohol (one or two glasses a 
day) should be avoided,” which was previously “Drinking up to 
two glasses a day”.23 The results of a recent meta-analysis in 
South Korea also showed that moderate alcohol intake has no 
beneficial effect on total mortality,19 supporting current con-
siderations to extend the application of this drinking guideline 
to other chronic diseases, such as stroke. However, data are 
scarce on the relationship between alcohol consumption and 
chronic diseases, such as diabetes and CVD, in Korea, and in-
formation on safe levels of alcohol consumption for diseases 
of interest is hard to find. Thus, it is necessary to accumulate 
scientific evidence on the effects of alcohol consumption on 
health outcomes in order to establish a health policy that pro-
motes a desirable alcohol intake and drinking pattern in this 
population.
THE EPIDEMIOLOGY OF GENETIC 
DIFFERENCES IN ALCOHOL USE: ALDH2 
AS A GENETIC MARKER FOR ALCOHOL 
CONSUMPTION
Alcohol consumption behavior is considered to reflect com-
plex etiology, involving environmental (e.g., cultural, social, and 
political) and genetic factors.24-26 Although some studies of al-
cohol use support this general understanding,27,28 there is evi-
dence that genetic variations, such as ALDH2*2 and alcohol 
dehydrogenase 1B (ADH1B)*2, have measurable effects on al-
cohol consumption in East Asians.29-31 Consistently, a genome-
wide association study in a Korean population identified ge-
netic loci associated with alcohol intake.32 According to this 
report, genes, including C12orf51, CCDC63, MYL2, OAS3, 
CUX2, and RPH3A, are in high linkage disequilibrium (LD) 
with the ALDH2 gene and are associated with amounts of al-
cohol consumed. Particularly, a genetic polymorphism in 
C12orf51 (rs2074356) at 12q24.13, which was in substantial 
LD with several intronic single nucleotide polymorphisms in 
ALDH2, such as rs2238151, showed the highest correlation 
with alcohol consumption and was associated with delayed 
acetaldehyde catabolism.33 Another study in a Korean popula-
tion reported that ADH1B*47Arg and ALDH2*487Glu, which 
affect alcohol metabolism, explained 86.5% of Korean alco-
holics.34 This study also suggested that individuals who have 
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the ADH1B*47Arg allele and the susceptible ALDH2*487Glu al-
lele at either loci had 11 times greater risk for alcoholism. Based 
on these observations, it is possible that these two genes, which 
are closely related to alcohol metabolism, could well explain 
the reason for alcohol intake and the probability of becoming 
an alcoholic in Koreans. Several genetic polymorphisms in 
ADH1B and ALDH2 reportedly generate functional differences 
in the activities of enzymes involved in alcohol metabolism, 
which influence the level of acetaldehyde, an intermediate 
metabolite of alcohol in the body. Generally, ALDH2 variation 
has a strong effect on alcohol metabolism, affecting blood lev-
els of acetaldehyde to a greater extent than ADH1B (Fig. 1A)29,35,36 
A study in a Korean population reported the lack of a signifi-
cant association between the ADH1B genotype and self-rating 
of the effects of alcohol.36 In line with this, a previous study in 
Asian-Americans also showed that the ALDH2*2 variant had 
a protective effect on alcohol use behavior, whereas the ADH1B 
variant was not associated with alcohol consumption.35 How-
ever, this requires further confirmation in other populations. 
Additionally, in East Asian populations (Chinese, Japanese, 
Korean, and Thai), the possession of two ALDH2*2 alleles was 
associated with a nine-fold reduction in alcohol consumption, 
whereas the possession of two ADH1B*2 alleles was associated 
with a five-fold reduction.29 Thus, particular attention has been 
focused on the roles of genetic variants in ALDH2 in alcohol 
metabolism. Interestingly, reports show that up to 50% of East 
Asians9,37,38 and about 25–35% of Koreans have an inactive form 
of ALDH2,39,40 which is scarce in North Americans or Europe-
ans (Fig. 1B). The inactive form of ALDH2 due to genetic vari-
ation causes the accumulation of acetaldehyde in the body, 
which leads to physiologic adverse effects, such as flushing, 
palpitations, headache, and displeasure,41 as well as a behav-
ioral influence in refraining from alcohol consumption. This 
genetically chosen behavior helps lower the chances of being 
alcoholic and reduces exposure to its associated risks. In this 
regard, several studies have proposed the use of ALDH2 as a 
biomarker for alcoholism.41,42
ACETALDEHYDE METABOLISM, 
PHYSIOLOGICAL RESPONSES, AND 
HEALTH EFFECTS OF ALDH2 VIA 
ALCOHOL CONSUMPTION ACCORDING 
TO ALDH2 VARIANTS
Numerous studies have reported differences in alcohol me-
tabolism, physiological functions, and drinking behavior ac-
cording to the rs671 genetic polymorphism. Specifically, hetero-
zygous individuals (ALDH2*1/*2) exhibit slower acetaldehyde 
degradation rates, equating to markedly higher levels of acet-
aldehyde than in homozygotes (ALHD2*1/*1),5 which was also 
verified in Koreans.43,44 It is generally accepted that high acet-
aldehyde levels in the blood exert negative effects on cardio-
vascular functions, causing subsequent elevations in heart 
rate, cardiac output, and blood flow velocity in the facial ar-
tery.45 Also, the accumulation of acetaldehyde over time induc-
es various symptoms, including facial flushing.46 According to a 
survey of 250 Thai people,47 80% of those with the ALDH2*1/*2 
genotype responded that they experienced flushing immedi-
ately after drinking alcohol. In contrast, only 28% of those with 
the ALDH2*1/*1 genotype answered that they experienced 
flushing immediately after alcohol consumption. This was fur-
ther supported by a clinical study48 showing that the ALDH2*1/*2 
genotype raised the heart rate and induced facial flushing in 
Fig. 1. Alcohol metabolism according to genetic polymorphisms. (A) Alde-
hyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) 
are involved in alcohol metabolism. Generally, ALDH2 variants have a 
greater influence on alcohol intake than ADH1B variants in East Asians. 
(B) ALDH2 variants mainly exist in East Asian populations. Adapted from 
Cho, et al. Sci Rep 2015;5:18422.6
Ethanol Acetaldehyde Acetate
ADH ALDH
ADH1B*1 ALDH2*1/1
ALDH2*1/2
ADH1B*2 ALDH2*2/2
Fig. 2. Scheme of the Mendelian randomization approach. The scheme of 
the Mendelian randomization approach. (A) This method uses a genetic 
variant, which proxies for exposure that is expected to be related to the 
outcome. (B) Using the Mendelian randomization approach, the causal 
effects of alcohol intake on cardiovascular outcomes can be investigated 
while controlling confounders and reverse causation. ALDH2, aldehyde 
dehydrogenase 2.
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variant
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Intermediate
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B
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individuals after alcohol consumption relative to those with 
the ALDH2*1/*1 genotype. Moreover, there is also evidence 
that the ALDH2*1/*2 genotype aggravates psychomotor func-
tions relative to the ALDH2*1/*1 genotype in Koreans.49,50
While people with the inactive form of ALDH2 tend to re-
frain from alcohol consumption, thus decreasing their expo-
sure to associated risks, the inactive form of ALDH2 also man-
ifests negative effects on health because of the toxicity of 
accumulated acetaldehyde after drinking. So far, studies on an 
ALDH2 variant (the rs671 allele) have suggested that an alter-
ation in ALDH2 activity caused by genetic variation is associ-
ated with a 20–60% increase in susceptibility to CVD and can-
cer in Asians.51-54 However, previous studies have not considered 
the possible association between alcohol drinking behavior 
caused by the ALDH2 variant and CVD.55 Similarly, associa-
tions observed by Gu and Li52 and Wang, et al.53 between the 
ALDH2*504lys allele and increased risk of myocardial infarc-
tion were based on ordinary least square estimates. In addition, 
an association study in a Chinese population reported that 
the ALDH2 Glu504Lys polymorphism was associated with the 
risk for hypertension in men, but not in women, who consumed 
relatively lower amounts of alcohol independent of their gen-
otype.54 Such a difference in the association between men and 
women provides evidence that the ALDH2 polymorphism in-
fluences outcomes only through alcohol intake.56 This is in line 
with recent studies showing that lower alcohol intake in indi-
viduals with the rs671 A allele, compared to wild-type homozy-
gotes,57,58 was associated with reduced cardiometabolic diseases, 
glucose levels, and blood pressure in men, who generally 
consumed more alcohol than women.
It was recently reported that Koreans with the inactive form 
of ALDH2 had a higher incidence of myocardial infarction due 
to the accumulation of acetaldehyde.59 However, alcohol in-
take had not been taken into account in the evaluation of the 
association between ALDH2 and CVD. Additionally, another 
study in the Korean population reported a 52% lower inci-
dence of lung cancer in nondrinkers with the inactive form of 
ALDH2 than those without.60 Based on evidence that ALDH2*2*2 
homozygotes consume considerably less alcohol than the 
wild-type homozygotes (ALDH2*1), with heterozygotes con-
suming intermediate amounts,8 it might be more reasonable to 
consider ALDH2 as a proxy for alcohol intake when investigat-
ing the effect of ALDH2 variants on CVD outcomes.
MENDELIAN RANDOMIZATION 
ANALYSIS BASED ON ALDH2 
POLYMORPHISMS
Recently, our research group tested whether alcohol intake is 
associated with cardiovascular risks in the Korean population, 
using genetic variation in ALDH2 (rs671) as a proxy for alco-
hol intake, in a MR framework (Fig. 2).6 We demonstrated, for 
the first time in a Korean population, a causal relationship be-
tween alcohol intake and hypertension and several cardio-
metabolic risk factors using an MR method that eliminated 
interference by confounders.61 Many epidemiologic studies 
have shown that moderate alcohol intake protects individuals 
against CVDs, as reflected by the J-shaped correlation,15 are 
limited by confounding variables, including smoking and so-
cioeconomic position, and reverse causation due to the char-
acteristics of observational studies. For example, light or mod-
erate alcohol users also tend to have other characteristics that 
are particularly beneficial to health, such as high income levels, 
good education, and regular exercise (confounding). Also, 
people diagnosed with chronic diseases tend to change their 
alcohol consumption patterns over time (reverse causation). 
In our previous study utilizing the MR framework,6 we found 
that the amount and pattern of alcohol intake are influenced 
by genotype and are associated with an increased risk for 
CVDs in a dose-dependent manner throughout life. Our find-
ings are consistent with those of a study using the MR method 
in Chinese individuals,11 which showed that alcohol intake is 
predicted by genetic polymorphisms in ALDH2 and has nega-
tive effects on blood pressure and blood triglyceride levels. It 
has yet to be determined whether the effects of genetic poly-
morphisms in ALDH2 on risk factors for CVD shown in our 
study, as well as those in other populations, are caused by the 
physiologic effects of these genetic variations or a subsequent 
result of alcohol intake (Table 1). A recent study in South Ko-
rea showed that genetic polymorphisms in ALDH2 are corre-
lated with stroke in men only,62 raising the possibility that the 
observed association is mainly attributable to the strong cor-
relation mediated by alcohol intake, especially in men. Fur-
ther, very recently, it has been suggested that alcohol flushing 
can be used as an instrumental variable to evaluate the health 
impact of alcohol consumption, since alcohol flushing is close-
ly related to ALDH2 deficiency.63 Using a phenotypic proxy of 
a genotype allows researchers to achieve MR-inspired causal 
inference even genetic data are absent.64
A GENETIC EDUCATION MODEL FOR 
ALCOHOL CONSUMPTION AND RELATED 
BEHAVIOR
According to a recent report in South Korea, the mortality rate 
of Korean men with chronic diseases, such as oral or laryngeal 
cancer, is approximately 30–40% and is attributable to alcohol 
consumption.65 In order to reduce alcohol intake more effec-
tively at the population level, novel personalized drinking 
guidelines incorporating genetic information, such as ALDH2 
variants, would be of value. It was previously reported that 
ALDH2 variants increased the risk of head and neck cancer 
only with the interaction with drinking alcohol, and ALDH2*1*2 
heterozygotes showed a less severe reaction to alcohol but an 
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Table 1. Mendelian Randomization Studies on Alcohol Consumption Predicted by Genotype and CVD Risk Factors
Author Population Instrument Outcome Statistics Major results
Jee, et al.69 Korean
  (n=2993 men and 
  1374 women)
rs671 in ALDH2 Serum glucose 
  levels
Instrumental 
  variable regression 
  analysis
An increase of 1 unit of alcohol with the G allele 
  of rs671 increased serum glucose levels in men.
Cho, et al.6 Korean 
  (n=3365 men and 
  3787 women)
rs671 in ALDH2 Risk factors 
  for CVD
Instrumental 
  variable regression 
  analysis
An increase of 1 unit of alcohol with the G allele 
  of rs671 increased CVD risk factors, including 
  blood pressure, waist-to-hip ratio, fasting blood 
  glucose, and TG levels.
Xu, et al.70 Chinese 
  (n=2321 men and 
  2757 women)
rs671 in ALDH2 Gamma-
  glutamyltransferase
Instrumental 
  variable regression 
  analysis
An increase of 1 unit of alcohol with the G allele 
  of rs671 increased gamma-glutamyltransferase 
  by 10.60 U/L per 10 g ethanol/day.
Au Yeung,
  et al.71
Chinese 
  (n=4588 men)
rs671 in ALDH2 Heart rate Instrumental 
  variable regression 
  analysis
An increase of 1 unit of alcohol with active 
  ALDH2 was associated with an increase 
  in heart rate of 0.98 beats per minute.
Au Yeung,
  et al.72
Chinese
  (n=4867 men)
rs671 in ALDH2 Self-reported CVD 
  and biologic CVD 
  risk factors
Instrumental 
  variable regression 
  analysis
An increase of 1 unit of alcohol with the G allele 
  of rs671 was associated with an increase in 
  HDL cholesterol per alcohol unit, and DBP, LDL 
  cholesterol, TG, or glucose, and the prevalence 
  of self-reported CVD.
Au Yeung,
  et al.73
Chinese
  (n=4707 men for 
  alcohol consumption 
  was not associated 
  with delayed 10-word 
  recall score; 2284 men 
  for MMSE score)
rs671 in ALDH2 Cognitive function Instrumental 
  variable regression 
  analysis
An increase of 1 unit of alcohol with the G allele 
  of rs671 was not associated with delayed 
  10-word recall score or MMSE score.
Tabara,
  et al.74
Japanese
  (n=2756 men and 
  5608 women)
ALDH2 LDL/HDL 
  cholesterol levels
Linear regression 
  analysis with an 
  additive genetic 
  model
The ALDH2*1 variant was strongly associated 
  with higher alcohol consumption in men. The 
  ALDH2*1 appeared causally related to increased 
  HDL cholesterol levels in men. The ALDH2 
  variant also related to decreased total 
  LDL cholesterol levels, while the LDL profiles 
  were worsened.
Tabara,
  et al.75
Japanese
  (n=2289 men and 
  1940 women)
ALDH2 LDL/HDL 
  cholesterol levels
Linear regression 
  analysis with an 
  additive genetic 
  model
The ALDH2*1 variant was strongly associated 
  with higher alcohol consumption in men. The 
  ALDH2*1 appeared causally related to 
  increased HDL cholesterol levels and reduced 
  LDL cholesterol levels in men.
Alcohol consumption was related to not only 
  increased HDL cholesterol levels but also 
  decreased LDL cholesterol levels and particle 
  numbers.
Taylor,
  et al.11 
Chinese
  (n=1712 diabetes 
  cases and 2076 
  controls)
rs671 in ALDH2 Cardiovascular and 
  metabolic factors
Linear regression 
  analysis with an 
  additive genetic 
  model
The A allele of rs671 was strongly associated 
  with reduced alcohol use in men and women. 
The A allele was associated with lower blood 
  pressure, lower HDL cholesterol and lower 
  triglycerides in men.
ALDH2, aldehyde dehydrogenase 2; CVD, cardiovascular disease; DBP, diastolic blood pressure; LDL, low-density lipid; HDL, high-density lipid; TG, triglyceride; 
MMSE, Mini-Mental State Examination.
The table only includes Mendelian randomization studies based on instrumental variable (IV) regression using rs671 in ALDH2 as an instrument. Papers included 
in Table 1 were collected from MEDLINE (http://www.ncbi.nlm.nih.gov/PubMed) using the following keywords: “Aldehyde dehydrogenase 2” and “ALDH2” in 
combination with “Mendelian randomization” and “alcohol.” The abstracts of the collected articles were scanned for inclusion of any cardiovascular-related 
outcomes of interest. We searched for all papers published before January 2017. The minimum requirement for inclusion was Mendelian randomization analysis 
using ALDH2 as an instrument. We excluded meta-analyses, because they did not perform IV regression analysis directly. Among the 20 papers identified by the 
search strategy, irrelevant articles (n=7) and meta-analyses (n=4) were excluded. When sufficient information could not be obtained, the study was excluded.
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elevated risk for cancer with the same amount of alcohol.8 In 
support of this, an animal study demonstrated that maternal 
deficiency in ALDH2 due to the ALDH2*2 allele resulted in ex-
tensive developmental malformations, particularly in cases of 
alcohol consumption during pregnancy. They also reported 
that genotoxic aldehydes in ALDH2*2 homozygous fetuses 
born from ALDH2*2 homozygous or heterozygous mothers 
who consumed alcohol were continuously accumulated, pos-
sibly resulting in birth defect.66 Given that approximately 30% 
of the Korean population are genetically deficient in ALDH2,6 
it would be effective if people could be informed about their 
own genetic predisposition to enable them to identify their 
own cardiovascular risks. A previous study on Health Risk Ap-
praisal Models, which made use of information on ALDH2 
variants to evaluate disease outcomes, supported this notion, 
showing high detection rate.67 In line with this, the inclusion 
of genetic information is now regarded as a very useful tool for 
educating alcohol intake and drinking behavior properly in 
community and/or clinical settings,68 yet still, such a genetic 
education model is not available in Korea. 
CONCLUSION
Although about 30% of Koreans have the inactive form of 
ALDH2, alcohol intake rates are still high in Koreans. This ge-
netically high-risk group represents a target for a customized 
alcohol-prevention program. In particular, the development 
of strategies using genetic information may prove necessary 
to modifying alcohol consumption behaviors in Korea. This 
novel approach is expected allow people to make informed de-
cision about their own alcohol consumption and, ultimately, 
raise public awareness of alcohol-gene interactions that is asso-
ciated with harmful drinking behavior and health outcomes. 
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